COLPAL NSI Week ended 07 Aug 2026

Weekly Investor Report

Colgate-Palmolive (India) Limited · Consumer Defensive · Household & Personal Products

Open interactive chart View report data
Latest close 2,030 INR
-2.1% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -1.7% below the Trend Line and sits at 37.5% of its 52-week range. The latest completed week returned -2.1%, after a -1.1% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is expensive relative to peers. The latest news-sentiment score is 53/100.

Setup score 40 out of 100
Latest Close 2,030 INR 7 Aug 2026
1W Return -2.1% latest completed week
4W Return -1.1% short-term follow-through
12W Return -4.9% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 1.4x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -2.1% Latest completed week; four-week move -1.1%. Indicator stack 0/58 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 53/100 37 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -1.7% below the Trend Line and sits at 37.5% of its 52-week range. The latest completed week returned -2.1%, after a -1.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1612-week average 0.24

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership3/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.16Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -1.1% over four weeks, -4.9% over 12 weeks, and -7.0% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-2.1%
4W-1.1%
12W-4.9%
26W-4.8%
52W-7.0%
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.39Latest activity-pressure read.
Pressure change13.8%Four-week change in activity pressure.
Leadership-3.63Latest relative-leadership reading.
RS change-121.0%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 91% Model confidence 85%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength26/100Blend of value, momentum, and quality. Underlying universe rank 75; rank 1 is best.
Value17/100Relative valuation strength. Underlying universe rank 84; rank 1 is best.
Quality95/100Profitability and accounting quality. Underlying universe rank 6; rank 1 is best.
Momentum34/100Medium-term price momentum. Underlying universe rank 67; rank 1 is best.
Growth12/100Revenue and earnings growth. Underlying universe rank 89; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
40.8x
Price divided by trailing earnings.
Price / sales
9.3x
Market value relative to trailing revenue.
EV / EBITDA
27.3x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
3.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
69.6%
Gross profit retained from each unit of revenue.
Operating margin
29.6%
Operating profit retained from revenue.
Free-cash-flow margin
29.2%
Free cash flow generated from revenue.
Return on invested capital
640.6%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-0.3%
Latest one-year revenue growth.
EPS growth
-7.8%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
30.7%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
2.4%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
2.4%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.7x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment53/100

Weighted news tone is neutral across 37 relevant articles.

6 positive · 27 neutral · 4 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-18.1%Distance below the 52-week high.
13-week volatility2.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher10 of 2616 weeks finished lower.
Best week+8.6%Week of 17 Apr.
Worst week-11.2%Week of 13 Mar.
Latest week-2.1%Week of 7 Aug.

Shape of recent returns

Strong gains3
Modest gains7
Flat weeks0
Modest losses14
Sharp losses2
Recent vol2.3%13-week weekly-return volatility.
Base vol3.3%52-week weekly-return volatility.
Up/down split22/30Count of positive and negative weeks in the 52-week window.
Average skew2.8% / -2.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape37/100

Trend, activity pressure, participation, and risk combine to a 37/100 tape read.

 Indicator analysis37/100

Latest 12-week confirmation: trend 0/12, activity pressure 12/12, relative leadership 3/12.

Activity pressure 0.16; No reversal markers Factors43/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 4 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment53/100

Weighted news tone is neutral across 37 relevant articles.

What to Know About Colgate-Palmolive Director John Cahill Selling 4,170 Shares for $389,353 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20262,030 INR-2.1%2,064 INR2,422 INR0.39-3.631.8MOff
31 Jul 20262,073 INR-0.6%2,065 INR2,421 INR0.49-0.993.3MOff
24 Jul 20262,086 INR2.1%2,066 INR2,420 INR0.432.081.6MOff
17 Jul 20262,042 INR-0.5%2,066 INR2,419 INR0.36-2.401.1MOff
10 Jul 20262,052 INR0.3%2,068 INR2,417 INR0.34-1.641.1MOff
3 Jul 20262,047 INR2.7%2,072 INR2,415 INR0.25-2.35136.7KOff
26 Jun 20261,993 INR-0.2%2,076 INR2,413 INR0.08-4.310Off
19 Jun 20261,998 INR-3.9%2,081 INR2,410 INR0.17-4.10417.5KOff
12 Jun 20262,079 INR4.0%2,087 INR2,407 INR0.211.19262.8KOff
5 Jun 20262,000 INR-1.8%2,091 INR2,404 INR0.28-1.76174.5KOff
29 May 20262,036 INR-4.5%2,096 INR2,401 INR0.48-0.973.8MOff
22 May 20262,132 INR-0.1%2,102 INR2,398 INR0.342.681.4MOff
15 May 20262,135 INR-1.7%2,105 INR2,394 INR0.402.981.6MOff
8 May 20262,172 INR4.8%2,110 INR2,390 INR0.392.121.5MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context